Listen to a recent interview with Yves De Koninck in which he explains the importance of the new drug tests that will soon start in the collaboration between Roche and Université Laval. The very promising drugs being tested were discovered over the last ten years of research in professor De Koninck’s laboratory.
If successful, these could lead to the development of new drugs to treat many neurological disease in as few as five years. The disease that could be treated include autism, chronic pain, epilepsy, even schizophrenia.
The interview is available here: http://www.cbc.ca/breakaway/2014/01/22/universite-laval-researches-autism-drug/